{"id":"F2007L04363","name":"National Health Act 1953 - Determination under section 85B - Price determinations and special patient contributions (No. PB 91 of 2007)","slug":"f2007l04363","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":326013,"registerId":"commonwealth-F2007L04363-current","compilationNumber":null,"startDate":"2026-04-08","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Determination under section 85B - Price determinations and special patient contributions (No. PB 91 of 2007)","content":"![](image.001.png)\n\nDetermination — Price determinations and special patient contributions (PB 91 of 2007)\n\nas amended\n\nmade under section 85B of the\n\nNational Health Act 1953\n\nThis compilation was prepared on 1 July 2008 \ntaking into account amendments up to PB 62 of 2008\n\nPrepared by the Office of Legislative Drafting and Publishing, \nAttorney-General’s Department, Canberra\n\nDetermination — Price determinations and special patient contributions (PB 91 of 2007)\n\nCommencement \\[see Note 1\\]\n\n1. This instrument commences on 1 December 2007.\n\nRepeal\n\n2. Instrument number PB 51 of 2007 is repealed.\n\nDefinition\n\n3. In this Determination “authority prescription” means a prescription which directs the supply of a pharmaceutical benefit and is a prescription authorised by, or taken to have been authorised by, the Chief Executive Officer of Medicare Australia in accordance with paragraph 12 of the determination made for the purposes of subsection 85A(2) of the Act.\n\nDetermined price\n\n4. For subsection 85B(2), the amount that is taken to be the appropriate maximum price for sales to approved pharmacists of a brand of a pharmaceutical item in Schedule 1 for the quantity or number of units mentioned for the brand is the price for that brand specified in the column headed “Determined price”.\n\nClaimed price\n\n5. For subsection 85B(3), the amount that is taken to be the price claimed by the responsible person as the responsible person's price for sales to approved pharmacists of a brand of a pharmaceutical item in Schedule 1 for the quantity or number of units mentioned for the brand is the price specified in the column headed “Claimed price”.\n\nCircumstances\n\n6. For the purposes of subsection 85B(5), the circumstances in which the Commonwealth is to pay the special patient contribution for brands of pharmaceutical items mentioned in Schedule 2 are that the brand has been supplied on an authority prescription.\n\n| Aciclovir | Tablet 200 mg | Oral | Zovirax 200 mg | 25 | 38.25 | 40.88 |\n| ---------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------- | --------------------- | --- | ------ | ------ |\n| | | Oral | Zovirax 200 mg | 90 | 139.97 | 143.86 |\n| | Tablet 800 mg | Oral | Zovirax 800 mg | 35 | 169.57 | 171.47 |\n| | | Oral | Zovirax 800 mg | 120 | 562.55 | 569.46 |\n| Alendronic Acid | Tablet 70 mg (as alendronate sodium) | Oral | Fosamax Once Weekly | 4 | 37.12 | 38.57 |\n| Allopurinol | Tablet 100 mg | Oral | Zyloprim | 200 | 7.85 | 10.06 |\n| | Tablet 300 mg | Oral | Zyloprim | 60 | 4.64 | 6.72 |\n| Alprazolam | Tablet 250 micrograms | Oral | Xanax | 50 | 3.62 | 4.57 |\n| | Tablet 500 micrograms | Oral | Xanax | 50 | 5.86 | 6.88 |\n| | Tablet 1 mg | Oral | Xanax | 50 | 10.21 | 11.41 |\n| | Tablet 2 mg | Oral | Xanax Tri-Score | 50 | 15.81 | 17.26 |\n| Amiodarone | Tablet containing amiodarone hydrochloride 100 mg | Oral | Cordarone X 100 | 30 | 10.00 | 10.88 |\n| | Tablet containing amiodarone hydrochloride 200 mg | Oral | Cordarone X 200 | 30 | 17.76 | 18.64 |\n| Amlodipine | Tablet 5 mg (as besylate) | Oral | Norvasc | 30 | 12.13 | 15.68 |\n| | Tablet 10 mg (as besylate) | Oral | Norvasc | 30 | 21.34 | 26.50 |\n| Amoxycillin | Tablet 1 g (as trihydrate) | Oral | Maxamox | 14 | 5.06 | 6.42 |\n| | Capsule 250 mg (as trihydrate) | Oral | Amoxil | 20 | 2.47 | 3.38 |\n| | Capsule 500 mg (as trihydrate) | Oral | Amoxil | 20 | 4.91 | 5.82 |\n| | Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | Oral | Amoxil | 1 | 3.68 | 4.21 |\n| | Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL | Oral | Amoxil | 1 | 2.20 | 3.31 |\n| | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL | Oral | Amoxil Forte | 1 | 3.17 | 4.09 |\n| Amoxycillin with Clavulanic Acid | Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | Augmentin Duo | 10 | 6.65 | 8.45 |\n| | Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | Augmentin Duo forte | 10 | 9.48 | 11.85 |\n| | Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL | Oral | Augmentin | 1 | 4.09 | 5.84 |\n| | Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral | Augmentin Duo 400 | 1 | 5.84 | 7.62 |\n| Aspirin | Tablet 100 mg | Oral | Astrix | 112 | 1.52 | 2.72 |\n| Atenolol | Tablet 50 mg | Oral | Tenormin | 30 | 4.46 | 7.69 |\n| Azathioprine | Tablet 25 mg | Oral | Imuran | 100 | 35.66 | 37.04 |\n| | Tablet 50 mg | Oral | Imuran | 100 | 60.71 | 62.02 |\n| Baclofen | Tablet 10 mg | Oral | Lioresal 10 | 100 | 29.74 | 32.37 |\n| | Tablet 25 mg | Oral | Lioresal 25 | 100 | 65.05 | 67.69 |\n| Betamethasone | Cream 200 micrograms (as valerate) per g, 100 g | Application | Betnovate 1/5 | 1 | 8.39 | 11.12 |\n| | Cream 500 micrograms (as valerate) per g, 15 g | Application | Betnovate 1/2 | 1 | 1.89 | 3.58 |\n| | Ointment 500 micrograms (as valerate) per g, 15 g | Application | Betnovate 1/2 | 1 | 1.89 | 3.58 |\n| Betaxolol | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Betoptic | 1 | 7.19 | 8.96 |\n| Bisacodyl | Suppositories 10 mg, 10 | Rectal | Dulcolax | 1 | 4.57 | 4.91 |\n| Bleomycin | Powder for injection containing bleomycin sulfate 15,000 I.U. (with any determined brand of sodium chloride injection as the required solvent) | Injection | Hospira Pty Limited | 1 | 47.66 | 90.54 |\n| | | Injection | Blenamax | 10 | 476.63 | 905.38 |\n| | | Injection | Blenoxane | 10 | 476.63 | 979.29 |\n| Brimonidine | Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL | Application to the eye | Alphagan | 1 | 12.93 | 14.47 |\n| Brinzolamide | Eye drops 10 mg per mL, 5 mL | Application to the eye | Azopt | 1 | 13.56 | 14.47 |\n| Bromocriptine | Tablet 2.5 mg (as mesylate) | Oral | Parlodel | 30 | 12.67 | 15.25 |\n| | | Oral | Parlodel | 60 | 25.32 | 27.97 |\n| | Capsule 5 mg (as mesylate) | Oral | Parlodel | 60 | 49.79 | 52.44 |\n| | Capsule 10 mg (as mesylate) | Oral | Parlodel | 100 | 178.33 | 181.24 |\n| Bupropion | Tablet containing bupropion hydrochloride 150 mg (sustained release) | Oral | Zyban | 30 | 65.71 | 66.50 |\n| | | Oral | Zyban | 90 | 150.38 | 151.17 |\n| Captopril | Tablet 12.5 mg | Oral | Capoten | 90 | 11.89 | 14.13 |\n| | Tablet 25 mg | Oral | Capoten | 90 | 17.21 | 20.54 |\n| | Tablet 50 mg | Oral | Capoten | 90 | 33.95 | 37.28 |\n| Carbamazepine | Tablet 100 mg | Oral | Tegretol 100 | 200 | 14.75 | 17.71 |\n| | Tablet 200 mg | Oral | Tegretol 200 | 200 | 27.57 | 30.75 |\n| Carbomer 980 | Ocular lubricating gel 2 mg per g, 10 g | Application to the eye | Viscotears Liquid Gel | 1 | 3.63 | 4.52 |\n| Cefaclor | Tablet (sustained release) 375 mg (as monohydrate) | Oral | Ceclor CD | 10 | 7.51 | 10.15 |\n| | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral | Ceclor | 1 | 5.28 | 7.59 |\n| | Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL | Oral | Ceclor | 1 | 5.65 | 8.04 |\n| Cefotaxime | Powder for injection 1 g (as sodium) | Injection | Cefotaxime Sandoz | 1 | 1.88 | 4.28 |\n| | Powder for injection 2 g (as sodium) | Injection | Cefotaxime Sandoz | 1 | 3.48 | 7.90 |\n| Cephalexin | Capsule 250 mg (anhydrous) | Oral | Keflex | 20 | 2.81 | 4.98 |\n| | Capsule 500 mg (anhydrous) | Oral | Keflex | 20 | 5.04 | 7.62 |\n| | Granules for oral suspension 125 mg per 5 mL, 100 mL | Oral | Keflex | 1 | 3.35 | 5.60 |\n| | Granules for oral suspension 250 mg per 5 mL, 100 mL | Oral | Keflex | 1 | 4.97 | 7.54 |\n| Cimetidine | Tablet 200 mg | Oral | Tagamet | 120 | 15.70 | 17.96 |\n| | Tablet 400 mg | Oral | Tagamet | 60 | 15.70 | 17.96 |\n| Ciprofloxacin | Tablet 250 mg (as hydrochloride) | Oral | Ciproxin 250 | 14 | 23.08 | 24.76 |\n| | Tablet 500 mg (as hydrochloride) | Oral | Ciproxin 500 | 14 | 45.10 | 46.78 |\n| | Tablet 750 mg (as hydrochloride) | Oral | Ciproxin 750 | 14 | 67.97 | 69.64 |\n| | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Ciloxan | 1 | 11.54 | 12.61 |\n| Citalopram | Tablet 20 mg (as hydrobromide) | Oral | Cipramil | 28 | 19.16 | 23.21 |\n| Clarithromycin | Tablet 250 mg | Oral | Klacid | 14 | 7.25 | 9.53 |\n| Clindamycin | Capsule 150 mg (as hydrochloride) | Oral | Dalacin C | 24 | 11.84 | 13.12 |\n| Clomiphene | Tablet containing clomiphene citrate 50 mg | Oral | Serophene | 10 | 30.93 | 31.09 |\n| | | Oral | Clomid | 10 | 30.93 | 34.21 |\n| Clomipramine | Tablet containing clomipramine hydrochloride 25 mg | Oral | Anafranil 25 | 50 | 12.07 | 15.04 |\n| Clonazepam | Tablet 500 micrograms | Oral | Rivotril | 100 | 7.99 | 10.07 |\n| | Tablet 2 mg | Oral | Rivotril | 100 | 15.02 | 17.38 |\n| Codeine with Paracetamol | Tablet containing codeine phosphate 30 mg with paracetamol 500 mg | Oral | Panadeine Forte | 20 | 1.92 | 3.59 |\n| Colchicine | Tablet 500 micrograms | Oral | Colgout | 100 | 4.18 | 4.99 |\n| Cyclosporin | Capsule 25 mg | Oral | Neoral 25 | 30 | 44.76 | 45.82 |\n| | Capsule 50 mg | Oral | Neoral 50 | 30 | 93.12 | 94.27 |\n| | Capsule 100 mg | Oral | Neoral 100 | 30 | 189.73 | 190.89 |\n| Cyproterone | Tablet containing cyproterone acetate 50 mg | Oral | Androcur | 20 | 55.76 | 59.93 |\n| | | Oral | Androcur | 50 | 122.20 | 124.20 |\n| | Tablet containing cyproterone acetate 100 mg | Oral | Androcur-100 | 50 | 197.98 | 199.99 |\n| Dexamethasone with Framycetin and Gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear | Sofradex | 1 | 2.08 | 3.64 |\n| Diazepam | Tablet 2 mg | Oral | Ducene | 50 | 1.80 | 2.59 |\n| | | Oral | Valium | 50 | 1.80 | 2.95 |\n| | Tablet 5 mg | Oral | Ducene | 50 | 2.00 | 2.83 |\n| | | Oral | Valium | 50 | 2.00 | 3.16 |\n| Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Voltaren 25 | 50 | 3.85 | 4.99 |\n| | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Voltaren 50 | 50 | 5.37 | 7.64 |\n| Digoxin | Tablet 62.5 micrograms | Oral | Lanoxin-PG | 200 | 3.77 | 5.35 |\n| | Tablet 250 micrograms | Oral | Lanoxin | 100 | 4.05 | 5.65 |\n| Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral | Cardizem | 90 | 11.36 | 13.39 |\n| | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD | 30 | 12.60 | 14.63 |\n| | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD | 30 | 17.01 | 19.04 |\n| | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD | 30 | 22.30 | 24.77 |\n| Diphenoxylate with Atropine | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate 25 micrograms | Oral | Lomotil | 20 | 1.95 | 3.57 |\n| Dothiepin | Capsule containing dothiepin hydrochloride 25 mg | Oral | Prothiaden | 50 | 2.59 | 4.41 |\n| | Tablet containing dothiepin hydrochloride 75 mg | Oral | Prothiaden | 30 | 2.57 | 3.51 |\n| Doxepin | Capsule 10 mg (as hydrochloride) | Oral | Sinequan | 50 | 2.22 | 3.84 |\n| | Capsule 25 mg (as hydrochloride) | Oral | Sinequan | 50 | 2.59 | 3.96 |\n| Doxycycline | Tablet 100 mg (as hydrochloride) | Oral | Vibramycin | 7 | 2.37 | 3.76 |\n| | Capsule 100 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Doryx | 7 | 2.37 | 3.70 |\n| | | Oral | Doryx | 21 | 7.07 | 9.49 |\n| | Tablet 50 mg (as hydrochloride) | Oral | Vibra-Tabs | 25 | 4.23 | 5.68 |\n| | Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Doryx | 25 | 4.23 | 5.74 |\n| Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Renitec M | 30 | 7.78 | 10.64 |\n| | Tablet containing enalapril maleate 10 mg | Oral | Amprace 10 | 30 | 12.78 | 15.64 |\n| | | Oral | Renitec | 30 | 12.78 | 15.64 |\n| | Tablet containing enalapril maleate 20 mg | Oral | Amprace 20 | 30 | 16.28 | 19.14 |\n| | | Oral | Renitec 20 | 30 | 16.28 | 19.14 |\n| Erythromycin | Tablet 400 mg (as ethyl succinate) | Oral | E.E.S. 400 Filmtab | 25 | 3.41 | 6.14 |\n| | Capsule 250 mg (containing enteric coated pellets) | Oral | Eryc | 25 | 3.49 | 5.05 |\n| | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E.E.S. 200 | 1 | 2.88 | 4.81 |\n| | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E.E.S. Granules | 1 | 4.31 | 5.86 |\n| Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexapro | 28 | 20.40 | 24.73 |\n| | Tablet 20 mg (as oxalate) | Oral | Lexapro | 28 | 20.52 | 26.88 |\n| | Oral solution 10 mg (as oxalate) per mL, 28 mL | Oral | Lexapro | 1 | 27.54 | 31.47 |\n| Famotidine | Tablet 20 mg | Oral | Pepcidine M | 60 | 12.75 | 17.67 |\n| | Tablet 40 mg | Oral | Pepcidine | 30 | 12.75 | 17.67 |\n| Felodipine | Tablet 2.5 mg (extended release) | Oral | Plendil ER | 30 | 8.18 | 12.73 |\n| | Tablet 5 mg (extended release) | Oral | Plendil ER | 30 | 11.26 | 15.81 |\n| | Tablet 10 mg (extended release) | Oral | Plendil ER | 30 | 20.16 | 24.71 |\n| Flecainide | Tablet containing flecainide acetate 100 mg | Oral | Tambocor | 60 | 36.62 | 39.14 |\n| Fluoxetine | Tablet, dispersible, 20 mg (as hydrochloride) | Oral | Prozac Tab | 28 | 16.68 | 21.46 |\n| | Capsule 20 mg (as hydrochloride) | Oral | Prozac 20 | 28 | 16.68 | 21.46 |\n| Fluvastatin | Capsule 20 mg (as sodium) | Oral | Vastin | 28 | 17.95 | 19.41 |\n| | Capsule 40 mg (as sodium) | Oral | Vastin | 28 | 22.00 | 23.58 |\n| Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | Luvox | 30 | 16.17 | 19.60 |\n| | Tablet containing fluvoxamine maleate 100 mg | Oral | Luvox | 30 | 24.49 | 27.92 |\n| Gemfibrozil | Tablet 600 mg | Oral | Lopid | 60 | 26.98 | 29.66 |\n| Glibenclamide | Tablet 5 mg | Oral | Daonil | 100 | 4.68 | 5.76 |\n| Gliclazide | Tablet 80 mg | Oral | Diamicron | 100 | 8.23 | 10.59 |\n| Glimepiride | Tablet 1 mg | Oral | Amaryl | 30 | 3.10 | 5.29 |\n| | Tablet 2 mg | Oral | Amaryl | 30 | 5.94 | 8.13 |\n| | Tablet 3 mg | Oral | Amaryl | 30 | 7.62 | 9.83 |\n| | Tablet 4 mg | Oral | Amaryl | 30 | 9.32 | 11.52 |\n| Glipizide | Tablet 5 mg | Oral | Minidiab | 100 | 4.77 | 8.38 |\n| Glyceryl Trinitrate | Tablets 600 micrograms, 100 | Buccal/sublingual | Anginine Stabilised | 1 | 5.30 | 6.76 |\n| Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 30 g | Application | Sigmacort | 1 | 2.33 | 4.01 |\n| | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortef | 1 | 2.02 | 2.09 |\n| | | Application | Sigmacort | 1 | 2.02 | 3.71 |\n| | Ointment containing hydrocortisone acetate 10 mg per g, 30 g | Application | Sigmacort | 1 | 2.33 | 4.01 |\n| | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | Sigmacort | 1 | 2.02 | 3.71 |\n| Hypromellose | Eye drops 3 mg per mL, 15 mL | Application to the eye | Genteal | 1 | 3.63 | 5.28 |\n| Hypromellose with Carbomer 980 | Ocular lubricating gel 3 mg-2 mg per g, 10 g | Application to the eye | Genteal gel | 1 | 3.63 | 5.28 |\n| Hypromellose with Dextran | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | Tears Naturale | 1 | 3.63 | 5.11 |\n| Imipramine | Tablet containing imipramine hydrochloride 10 mg | Oral | Tofranil 10 | 50 | 2.00 | 4.63 |\n| | Tablet containing imipramine hydrochloride 25 mg | Oral | Tofranil 25 | 50 | 2.00 | 4.63 |\n| Indapamide | Tablet containing indapamide hemihydrate 2.5 mg | Oral | Natrilix | 90 | 12.83 | 15.79 |\n| Indomethacin | Capsule 25 mg | Oral | Indocid | 50 | 2.45 | 3.81 |\n| Ipratropium | Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30 | Inhalation | Atrovent | 1 | 17.89 | 18.31 |\n| | Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30 | Inhalation | Atrovent Adult | 1 | 21.15 | 21.56 |\n| Isosorbide Mononitrate | Tablet 60 mg (sustained release) | Oral | Imdur Durule | 30 | 7.49 | 10.07 |\n| | Tablet 120 mg (sustained release) | Oral | Imdur 120 mg | 30 | 17.76 | 20.49 |\n| Isotretinoin | Capsule 20 mg | Oral | Roaccutane | 60 | 127.43 | 129.63 |\n| Ketoprofen | Capsule 200 mg (sustained release) | Oral | Orudis SR 200 | 28 | 9.32 | 11.09 |\n| Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral | Trandate | 100 | 8.35 | 11.00 |\n| | Tablet containing labetalol hydrochloride 200 mg | Oral | Trandate | 100 | 13.74 | 16.38 |\n| Lactulose | Solution BP 3.34 g per 5 mL, 500 mL | Oral | Duphalac | 1 | 9.05 | 10.99 |\n| Lamotrigine | Tablet 5 mg | Oral | Lamictal | 56 | 11.97 | 12.85 |\n| | Tablet 25 mg | Oral | Lamictal | 56 | 26.64 | 27.53 |\n| | Tablet 50 mg | Oral | Lamictal | 56 | 44.43 | 45.31 |\n| | Tablet 100 mg | Oral | Lamictal | 56 | 74.02 | 74.90 |\n| | Tablet 200 mg | Oral | Lamictal | 56 | 124.35 | 125.23 |\n| Lansoprazole | Sachet containing granules for oral suspension, 30 mg per sachet | Oral | Zoton | 28 | 27.85 | 31.15 |\n| Leflunomide | Tablet 10 mg | Oral | Arava | 30 | 82.60 | 83.66 |\n| | Tablet 20 mg | Oral | Arava | 30 | 125.76 | 126.83 |\n| Lercanidipine | Tablet containing lercanidipine hydrochloride 10 mg | Oral | Zanidip | 30 | 12.72 | 14.54 |\n| | Tablet containing lercanidipine hydrochloride 20 mg | Oral | Zanidip | 30 | 20.86 | 24.50 |\n| Levetiracetam | Tablet 250 mg | Oral | Keppra | 60 | 45.45 | 51.94 |\n| | Tablet 500 mg | Oral | Keppra | 60 | 75.80 | 86.63 |\n| | Tablet 1 g | Oral | Keppra | 60 | 126.28 | 144.32 |\n| Levodopa with Carbidopa | Tablet 100 mg-25 mg (anhydrous) | Oral | Sinemet 100/25 | 100 | 30.05 | 34.80 |\n| | Tablet 250 mg-25 mg (anhydrous) | Oral | Sinemet | 100 | 37.05 | 39.87 |\n| Levonorgestrel with Ethinyloestradiol | Tablets 150 micrograms-30 micrograms, 21 | Oral | Microgynon 30 | 4 | 9.97 | 20.13 |\n| | Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets | Oral | Microgynon 30 ED | 4 | 9.97 | 20.13 |\n| | | Oral | Nordette 28 | 4 | 9.97 | 20.43 |\n| | Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets | Oral | Triquilar ED | 4 | 9.97 | 20.13 |\n| | | Oral | Triphasil 28 | 4 | 9.97 | 20.43 |\n| Lisinopril | Tablet 5 mg | Oral | Prinivil 5 | 30 | 8.93 | 10.70 |\n| | | Oral | Zestril | 30 | 8.93 | 11.34 |\n| | Tablet 10 mg | Oral | Prinivil 10 | 30 | 13.41 | 15.18 |\n| | | Oral | Zestril | 30 | 13.41 | 15.82 |\n| | Tablet 20 mg | Oral | Prinivil 20 | 30 | 16.89 | 18.66 |\n| | | Oral | Zestril | 30 | 16.89 | 19.30 |\n| Loperamide | Capsule containing loperamide hydrochloride 2 mg | Oral | Imodium | 12 | 1.93 | 2.75 |\n| Medroxyprogesterone | Tablet containing medroxyprogesterone acetate 5 mg | Oral | Provera | 56 | 7.80 | 9.35 |\n| | Tablet containing medroxyprogesterone acetate 10 mg | Oral | Provera | 30 | 8.37 | 9.92 |\n| | | Oral | Provera | 100 | 22.89 | 24.34 |\n| | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection | Depo-Provera | 1 | 7.30 | 10.25 |\n| Meloxicam | Tablet 7.5 mg | Oral | Mobic | 30 | 13.92 | 15.35 |\n| | Tablet 15 mg | Oral | Mobic | 30 | 20.30 | 21.73 |\n| Metformin | Tablet containing metformin hydrochloride 500 mg | Oral | Glucophage | 100 | 7.73 | 9.01 |\n| | | Oral | Diabex | 100 | 7.73 | 9.36 |\n| | Tablet containing metformin hydrochloride 850 mg | Oral | Glucophage | 60 | 7.73 | 9.01 |\n| | | Oral | Diabex 850 | 60 | 7.73 | 9.36 |\n| | Tablet containing metformin hydrochloride 1 g | Oral | Diabex 1000 | 90 | 13.46 | 15.10 |\n| Methyldopa | Tablet 250 mg | Oral | Aldomet | 100 | 7.19 | 9.78 |\n| Methylphenidate | Tablet containing methylphenidate hydrochloride 10 mg | Oral | Ritalin 10 | 100 | 7.88 | 9.47 |\n| Methylprednisolone | Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection | Depo-Medrol | 5 | 16.32 | 16.99 |\n| Metoclopramide | Tablet containing metoclopramide hydrochloride 10 mg | Oral | Maxolon | 25 | 1.41 | 4.03 |\n| Metoprolol | Tablet containing metoprolol tartrate 50 mg | Oral | Lopresor 50 | 100 | 5.12 | 7.85 |\n| | | Oral | Betaloc | 100 | 5.12 | 8.07 |\n| | Tablet containing metoprolol tartrate 100 mg | Oral | Lopresor 100 | 60 | 6.50 | 9.23 |\n| | | Oral | Betaloc | 60 | 6.50 | 9.45 |\n| Metronidazole | Tablet 400 mg | Oral | Flagyl | 21 | 4.18 | 6.00 |\n| | Tablet 200 mg | Oral | Flagyl | 21 | 1.78 | 3.53 |\n| Mianserin | Tablet containing mianserin hydrochloride 10 mg | Oral | Tolvon | 50 | 8.45 | 10.21 |\n| | Tablet containing mianserin hydrochloride 20 mg | Oral | Tolvon | 50 | 17.84 | 20.47 |\n| Minocycline | Tablet 50 mg (as hydrochloride) | Oral | Minomycin-50 | 60 | 10.52 | 11.50 |\n| Mirtazapine | Tablet 30 mg | Oral | Avanza | 30 | 24.25 | 26.23 |\n| | Tablet 45 mg | Oral | Avanza | 30 | 40.42 | 42.41 |\n| Moclobemide | Tablet 150 mg | Oral | Aurorix | 60 | 14.31 | 15.15 |\n| | Tablet 300 mg | Oral | Aurorix 300 mg | 60 | 27.54 | 29.23 |\n| Naproxen | Tablet 250 mg | Oral | Naprosyn | 50 | 4.23 | 5.59 |\n| | Tablet containing naproxen sodium 550 mg | Oral | Anaprox 550 | 50 | 7.75 | 10.40 |\n| | Tablet 500 mg | Oral | Naprosyn | 50 | 7.52 | 9.11 |\n| | Tablet 750 mg (sustained release) | Oral | Naprosyn SR750 | 28 | 6.91 | 8.38 |\n| | Tablet 1 g (sustained release) | Oral | Naprosyn SR1000 | 28 | 9.21 | 10.77 |\n| Naratriptan | Tablet 2.5 mg (as hydrochloride) | Oral | Naramig | 2 | 8.47 | 9.68 |\n| Nifedipine | Tablet 10 mg | Oral | Adalat 10 | 60 | 10.94 | 12.31 |\n| | Tablet 20 mg | Oral | Adalat 20 | 60 | 13.63 | 16.18 |\n| | Tablet 20 mg (controlled release) | Oral | Adalat Oros 20mg | 30 | 13.59 | 16.21 |\n| | Tablet 30 mg (controlled release) | Oral | Adalat Oros 30 | 30 | 14.66 | 17.61 |\n| | Tablet 60 mg (controlled release) | Oral | Adalat Oros 60 | 30 | 18.42 | 21.68 |\n| Nitrazepam | Tablet 5 mg | Oral | Mogadon | 25 | 1.70 | 3.48 |\n| Nizatidine | Capsule 150 mg | Oral | Tazac | 60 | 14.65 | 21.15 |\n| | Capsule 300 mg | Oral | Tazac | 30 | 14.65 | 21.15 |\n| Norethisterone | Tablets 350 micrograms, 28 | Oral | Noriday 28 Day | 1 | 2.37 | 3.25 |\n| Norethisterone with Ethinyloestradiol | Tablets 500 micrograms-35 micrograms, 21 | Oral | Brevinor | 1 | 2.37 | 4.12 |\n| | Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets | Oral | Brevinor | 1 | 2.37 | 4.12 |\n| | Tablets 1 mg-35 micrograms, 21 | Oral | Brevinor-1 | 1 | 2.37 | 4.12 |\n| | Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets | Oral | Brevinor-1 | 1 | 2.37 | 4.12 |\n| | Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets | Oral | Synphasic | 1 | 2.37 | 4.12 |\n| Norfloxacin | Tablet 400 mg | Oral | Noroxin | 14 | 13.11 | 16.39 |\n| Omeprazole | Tablet 20 mg (as magnesium) | Oral | Losec Tablets | 30 | 26.57 | 29.07 |\n| Ondansetron | Tablet 4 mg (as hydrochloride dihydrate) | Oral | Zofran | 4 | 30.51 | 31.13 |\n| | | Oral | Zofran | 10 | 76.26 | 76.89 |\n| | Tablet 8 mg (as hydrochloride dihydrate) | Oral | Zofran | 4 | 47.79 | 48.42 |\n| | | Oral | Zofran | 10 | 119.47 | 120.09 |\n| | Wafer 4 mg | Oral | Zofran Zydis | 4 | 30.51 | 31.13 |\n| | | Oral | Zofran Zydis | 10 | 76.26 | 76.89 |\n| | Wafer 8 mg | Oral | Zofran Zydis | 4 | 47.79 | 48.42 |\n| | | Oral | Zofran Zydis | 10 | 119.47 | 120.09 |\n| | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | Zofran | 1 | 17.20 | 17.83 |\n| | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | Zofran | 1 | 27.33 | 27.94 |\n| Oxazepam | Tablet 15 mg | Oral | Serepax | 25 | 1.13 | 2.71 |\n| | Tablet 30 mg | Oral | Serepax | 25 | 1.31 | 2.99 |\n| Paracetamol | Tablet 665 mg (modified release) | Oral | Panadol Osteo | 96 | 2.97 | 5.12 |\n| Paraffin | Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye | Duratears | 1 | 6.69 | 7.60 |\n| | Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye | Lacri-Lube | 1 | 13.37 | 15.36 |\n| Paroxetine | Tablet 20 mg (as hydrochloride) | Oral | Aropax | 30 | 22.09 | 23.09 |\n| Pilocarpine | Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL | Application to the eye | P.V. Carpine | 1 | 5.76 | 8.40 |\n| | Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL | Application to the eye | P.V. Carpine | 1 | 6.94 | 9.56 |\n| | Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL | Application to the eye | P.V. Carpine | 1 | 9.62 | 12.13 |\n| | Eye drops containing pilocarpine hydrochloride 60 mg per mL, 15 mL | Application to the eye | P.V. Carpine | 1 | 13.86 | 16.40 |\n| Pindolol | Tablet 5 mg | Oral | Visken 5 | 100 | 5.87 | 8.34 |\n| | Tablet 15 mg | Oral | Visken 15 | 50 | 8.45 | 10.90 |\n| Piperazine Oestrone | Tablet 730 micrograms (as sulfate) | Oral | Ogen .625 | 56 | 4.95 | 6.25 |\n| | Tablet 1.46 mg (as sulfate) | Oral | Ogen 1.25 | 56 | 7.05 | 8.37 |\n| Piroxicam | Dispersible tablet 10 mg | Oral | Feldene-D | 50 | 7.05 | 9.47 |\n| | Dispersible tablet 20 mg | Oral | Feldene-D | 25 | 6.70 | 9.10 |\n| | Capsule 10 mg | Oral | Feldene | 50 | 7.05 | 9.47 |\n| | Capsule 20 mg | Oral | Feldene | 25 | 6.70 | 9.10 |\n| Polyvinyl Alcohol | Eye drops 14 mg per mL, 15 mL | Application to the eye | Liquifilm Tears | 1 | 3.63 | 5.14 |\n| | Eye drops 30 mg per mL, 15 mL | Application to the eye | Liquifilm Forte | 1 | 3.63 | 8.90 |\n| Potassium Chloride | Tablet 600 mg (sustained release) | Oral | Slow-K | 100 | 3.05 | 4.30 |\n| Potassium Chloride with Potassium Bicarbonate | Tablet, effervescent, 14 mmol potassium and 8 mmol chloride | Oral | Chlorvescent | 60 | 5.90 | 8.21 |\n| Pravastatin | Tablet containing pravastatin sodium 10 mg | Oral | Pravachol | 30 | 17.66 | 21.75 |\n| | Tablet containing pravastatin sodium 20 mg | Oral | Pravachol | 30 | 28.06 | 32.15 |\n| | Tablet containing pravastatin sodium 40 mg | Oral | Pravachol | 30 | 43.71 | 47.80 |\n| | Tablet containing pravastatin sodium 80 mg | Oral | Pravachol | 30 | 67.01 | 71.10 |\n| Prazosin | Tablet 1 mg (as hydrochloride) | Oral | Minipress | 100 | 7.19 | 9.87 |\n| | Tablet 2 mg (as hydrochloride) | Oral | Minipress | 100 | 9.86 | 12.63 |\n| | Tablet 5 mg (as hydrochloride) | Oral | Minipress | 100 | 16.73 | 19.72 |\n| Prednisolone | Tablet 1 mg | Oral | Panafcortelone | 100 | 2.33 | 2.87 |\n| | Oral solution 5 mg (as sodium phosphate) per mL, 30 mL | Oral | Redipred | 1 | 7.58 | 9.20 |\n| Prednisone | Tablet 1 mg | Oral | Panafcort | 100 | 2.29 | 2.87 |\n| Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | Stemetil | 25 | 2.28 | 4.18 |\n| Propranolol | Tablet containing propranolol hydrochloride 10 mg | Oral | Inderal | 100 | 3.28 | 6.01 |\n| | Tablet containing propranolol hydrochloride 40 mg | Oral | Inderal | 100 | 3.60 | 6.33 |\n| Quinapril | Tablet 5 mg (as hydrochloride) | Oral | Accupril | 30 | 9.53 | 9.97 |\n| | Tablet 10 mg (as hydrochloride) | Oral | Accupril | 30 | 13.43 | 14.03 |\n| | Tablet 20 mg (as hydrochloride) | Oral | Accupril | 30 | 16.56 | 17.45 |\n| Quinine | Tablet containing quinine sulfate 300 mg | Oral | Quinate | 50 | 5.35 | 7.28 |\n| Ramipril | Tablet 1.25 mg | Oral | Tritace 1.25 mg | 30 | 6.35 | 9.08 |\n| | Tablet 2.5 mg | Oral | Tritace 2.5 mg | 30 | 9.28 | 12.01 |\n| | Tablet 5 mg | Oral | Tritace 5 mg | 30 | 11.64 | 14.36 |\n| | Tablet 10 mg | Oral | Tritace | 30 | 20.54 | 23.26 |\n| | Capsule 10 mg | Oral | Tritace 10 mg | 30 | 20.54 | 23.26 |\n| Ranitidine | Tablet 150 mg (as hydrochloride) | Oral | Zantac | 60 | 13.28 | 15.25 |\n| | Tablet, effervescent, 150 mg (as hydrochloride) | Oral | Zantac | 30 | 6.65 | 8.55 |\n| | Tablet 300 mg (as hydrochloride) | Oral | Zantac | 30 | 13.28 | 15.25 |\n| | Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL | Oral | Zantac Syrup | 1 | 6.65 | 7.61 |\n| Roxithromycin | Tablet 150 mg | Oral | Rulide | 10 | 6.18 | 8.38 |\n| | Tablet 300 mg | Oral | Rulide | 5 | 6.18 | 8.38 |\n| Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Ventolin CFC-free | 1 | 5.11 | 5.79 |\n| | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation | Ventolin Nebules | 1 | 7.25 | 8.10 |\n| | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation | Ventolin Nebules | 1 | 7.67 | 8.51 |\n| Sertraline | Tablet 50 mg (as hydrochloride) | Oral | Zoloft | 30 | 21.14 | 21.63 |\n| | Tablet 100 mg (as hydrochloride) | Oral | Zoloft | 30 | 21.14 | 21.63 |\n| Simvastatin | Tablet 5 mg | Oral | Zocor | 30 | 15.65 | 16.86 |\n| | Tablet 10 mg | Oral | Lipex 10 | 30 | 21.63 | 22.84 |\n| | | Oral | Zocor | 30 | 21.63 | 22.84 |\n| | Tablet 20 mg | Oral | Lipex 20 | 30 | 31.09 | 32.30 |\n| | | Oral | Zocor | 30 | 31.09 | 32.30 |\n| | Tablet 40 mg | Oral | Lipex 40 | 30 | 44.74 | 45.95 |\n| | | Oral | Zocor | 30 | 44.74 | 45.95 |\n| | Tablet 80 mg | Oral | Lipex 80 | 30 | 64.30 | 65.51 |\n| | | Oral | Zocor | 30 | 64.30 | 65.51 |\n| Sotalol | Tablet containing sotalol hydrochloride 80 mg | Oral | Sotacor | 60 | 10.85 | 14.95 |\n| | Tablet containing sotalol hydrochloride 160 mg | Oral | Sotacor | 60 | 23.28 | 27.37 |\n| Spironolactone | Tablet 25 mg | Oral | Aldactone | 100 | 7.04 | 8.71 |\n| | Tablet 100 mg | Oral | Aldactone | 100 | 27.71 | 30.01 |\n| Sucralfate | Tablet equivalent to 1 g anhydrous sucralfate | Oral | Carafate | 120 | 15.96 | 17.90 |\n| Sulfasalazine | Tablet 500 mg (enteric coated) | Oral | Salazopyrin-EN | 100 | 23.48 | 24.21 |\n| Tamoxifen | Tablet 10 mg (as citrate) | Oral | Nolvadex | 30 | 18.82 | 19.78 |\n| | Tablet 20 mg (as citrate) | Oral | Nolvadex-D | 30 | 32.62 | 34.35 |\n| Temazepam | Tablet 10 mg | Oral | Normison | 25 | 1.70 | 3.31 |\n| Terbinafine | Tablet 250 mg (as hydrochloride) | Oral | Lamisil | 42 | 116.85 | 118.61 |\n| Thyroxine | Tablet containing 50 micrograms anhydrous thyroxine sodium | Oral | Oroxine | 200 | 15.98 | 17.13 |\n| | Tablet containing 100 micrograms anhydrous thyroxine sodium | Oral | Oroxine | 200 | 16.55 | 17.71 |\n| | Tablet containing 200 micrograms anhydrous thyroxine sodium | Oral | Oroxine | 200 | 19.41 | 20.55 |\n| Ticlopidine | Tablet containing ticlopidine hydrochloride 250 mg | Oral | Ticlid | 60 | 129.93 | 131.93 |\n| Timolol | Eye drops 2.5 mg (as maleate) per mL, 5 mL | Application to the eye | Timoptol | 1 | 6.24 | 7.60 |\n| | Eye drops 5 mg (as maleate) per mL, 5 mL | Application to the eye | Timoptol | 1 | 7.19 | 8.55 |\n| Tinidazole | Tablet 500 mg | Oral | Fasigyn | 4 | 2.47 | 4.69 |\n| Tramadol | Capsule containing tramadol hydrochloride 50 mg | Oral | Tramal | 20 | 3.17 | 5.99 |\n| | Tablet containing tramadol hydrochloride 100 mg (sustained release) | Oral | Tramal SR 100 | 20 | 8.63 | 13.85 |\n| | Tablet containing tramadol hydrochloride 150 mg (sustained release) | Oral | Tramal SR 150 | 20 | 11.63 | 17.85 |\n| | Tablet containing tramadol hydrochloride 200 mg (sustained release) | Oral | Tramal SR 200 | 20 | 14.16 | 21.21 |\n| Trandolapril | Capsule 500 micrograms | Oral | Gopten | 28 | 6.70 | 8.52 |\n| | | Oral | Odrik | 28 | 6.70 | 9.43 |\n| | Capsule 1 mg | Oral | Gopten | 28 | 10.85 | 12.67 |\n| | | Oral | Odrik | 28 | 10.85 | 13.58 |\n| | Capsule 2 mg | Oral | Gopten | 28 | 11.77 | 13.59 |\n| | | Oral | Odrik | 28 | 11.77 | 14.50 |\n| | Capsule 4 mg | Oral | Gopten | 28 | 22.36 | 24.18 |\n| Triamcinolone | Cream containing triamcinolone acetonide 200 micrograms per g, 100 g | Application | Aristocort 0.02% | 1 | 3.76 | 5.21 |\n| | Ointment containing triamcinolone acetonide 200 micrograms per g, 100 g | Application | Aristocort 0.02% | 1 | 3.76 | 5.21 |\n| Triamcinolone with Neomycin, Gramicidin and Nystatin | Ear drops containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 7.5 mL | Application to the ear | Kenacomb Otic | 1 | 4.40 | 5.35 |\n| | Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g | Application to the ear | Kenacomb Otic | 1 | 1.65 | 2.61 |\n| Trimethoprim | Tablet 300 mg | Oral | Triprim | 7 | 2.39 | 3.59 |\n| Trimethoprim with Sulfamethoxazole | Tablet 160 mg-800 mg | Oral | Septrin Forte | 10 | 3.44 | 4.72 |\n| | Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL | Oral | Septrin | 1 | 3.05 | 4.74 |\n| Valproic Acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral | Epilim EC | 100 | 12.17 | 12.68 |\n| | Tablet (enteric coated) containing sodium valproate 500 mg | Oral | Epilim EC | 100 | 24.10 | 24.73 |\n| Verapamil | Tablet containing verapamil hydrochloride 40 mg | Oral | Isoptin | 100 | 5.90 | 6.78 |\n| | Tablet containing verapamil hydrochloride 80 mg | Oral | Isoptin | 100 | 10.48 | 11.36 |\n| | Tablet containing verapamil hydrochloride 180 mg (sustained release) | Oral | Isoptin 180 SR | 30 | 8.46 | 11.09 |\n| | Tablet containing verapamil hydrochloride 240 mg (sustained release) | Oral | Isoptin SR | 30 | 11.28 | 13.91 |\n| Zolmitriptan | Tablet 2.5 mg | Oral | Zomig | 2 | 8.44 | 9.64 |\n\n| Amoxycillin | Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | Oral | Amoxil |\n| ------------- | --------------------------------------------------------------------- | ---- | ---------------- |\n| Escitalopram | Oral solution 10 mg (as oxalate) per mL, 28 mL | Oral | Lexapro |\n| Lansoprazole | Sachet containing granules for oral suspension, 30 mg per sachet | Oral | Zoton |\n| Lercanidipine | Tablet containing lercanidipine hydrochloride 10 mg | Oral | Zanidip |\n| | Tablet containing lercanidipine hydrochloride 20 mg | Oral | Zanidip |\n| Levetiracetam | Tablet 250 mg | Oral | Keppra |\n| | Tablet 500 mg | Oral | Keppra |\n| | Tablet 1 g | Oral | Keppra |\n| Naratriptan | Tablet 2.5 mg (as hydrochloride) | Oral | Naramig |\n| Nifedipine | Tablet 20 mg (controlled release) | Oral | Adalat Oros 20mg |\n| Ranitidine | Tablet, effervescent, 150 mg (as hydrochloride) | Oral | Zantac |\n| | Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL | Oral | Zantac Syrup |\n| Zolmitriptan | Tablet 2.5 mg | Oral | Zomig |\n\n> Notes to the Determination — Price determinations and special patient contributions (PB 91 of 2007)\n\n> Note 1\n\n> Note: The Determination — Price determinations and special patient contributions \n> (PB 91 of 2007) (in force under section 85B of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.\n\n> Note: > Note: Table of Instruments\n\n| Title | Date of FRLI Registration | Date ofcommencement | Application, saving ortransitional provisions |\n| ------------- | ------------------------------ | ------------------- | --------------------------------------------- |\n| PB 91 of 2007 | 16 Nov 2007 (see F2007L04363) | 1 Dec 2007 | |\n| PB 9 of 2008 | 19 Dec 2007 (see F2007L04907) | 1 Jan 2008 | — |\n| PB 26 of 2008 | 11 Feb 2008 (see F2008L00284) | 1 Mar 2008 | — |\n| PB 33 of 2008 | 11 Mar 2008 (see F2008L00698) | 1 Apr 2008 | — |\n| as amended by | | | |\n| PB 40 of 2008 | 26 Mar 2008 (see F2008L00958) | (a) | — |\n| PB 44 of 2008 | 10 Apr 2008 (see F2008L01032) | 1 May 2008 | — |\n| PB 53 of 2008 | 12 May 2008 (see F2008L01385) | 1 June 2008 | — |\n| PB 62 of 2008 | 10 June 2008 (see F2008L02052) | 1 July 2008 | — |\n\n> Note: (a) Section 1 of PB 40 of 2008 provides as follows:\n\n> Note: 1. Commencement\n\n> Note: This instrument commences at 8 pm on 31 March 2008.\n\n> Note: > Note: Table of Amendments\n\n```html\n

ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted

Provision affected

How affected

Schedule 1

Schedule 1................

am. PB 9, 26, 33, 44, 53 and 62 of 2008

Schedule 2

Schedule 2................

am. PB 33 of 2008

\n```","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":2172},"content_quality":"ok","complexity_score":3,"scope_assessment":{"changed":false,"description":"This determination operates within its original scope as a price-setting instrument under section 85B of the National Health Act 1953. It sets prices for pharmaceutical benefits and defines circumstances for special patient contributions, which is the standard and intended function of such determinations. The amendments shown in the compilation merely update specific prices and items within the existing framework."},"complexity_factors":["Extensive tabular schedules listing hundreds of specific pharmaceutical items with precise chemical formulations, dosages, pack sizes, and dual pricing columns","Single defined term ('authority prescription') cross-referencing subsection 85A(2) of the National Health Act 1953","Simple operative structure with only four substantive sections (definitions, determined price, claimed price, circumstances for special contributions)","Technical pharmaceutical terminology requiring specialised medical and chemical knowledge to interpret specific entries"],"plain_english_summary":"This determination fixes the maximum amounts the Commonwealth will pay pharmacists for hundreds of PBS‑listed medicines, records the manufacturers’ claimed selling prices, and stipulates that for certain listed medicines the Commonwealth pays only a special patient contribution when supplied on an authority prescription. It affects patients receiving subsidised or restricted medicines, the pharmacists reimbursed under the PBS, and pharmaceutical companies whose revenues depend on the recorded prices."},"flash_summary":{"complexity_score":7,"scope_assessment":{"changed":false,"description":"This Determination operates within the statutory remit of section 85B of the National Health Act 1953: it fixes prices and specifies when special patient contributions are payable. The amendments listed update schedules, prices and commencement dates but do not expand or narrow the Determination's overarching legal scope under the Act; they are iterative updates to the same price- and contribution-setting function."},"complexity_factors":["Large, detailed Schedule 1 listing many brands, strengths, pack sizes and two separate price columns (\"Determined price\" and \"Claimed price\") increases operational complexity for pharmacies and payers.","Cross-references to multiple statutory subsections (uses subsection 85B(2), 85B(3) and 85B(5)) require reading the Act alongside the Determination (secs 4–6).","Definition of \"authority prescription\" refers to an external instrument (paragraph 12 of the determination made for subsection 85A(2)), creating dependency on another instrument (s3).","Special patient contribution payment is conditional: Commonwealth pays only for brands listed in Schedule 2 and only when supplied on an authority prescription (s6), narrowing entitlement and requiring verification.","The instrument repeals a prior instrument (PB 51 of 2007) (s2) and has multiple later amendments (PB 9, 26, 33, 40, 44, 53, 62 of 2008) increasing the need to track versions and commencement timings (s1 and Notes).","Roles and terms such as \"approved pharmacists\" and \"responsible person\" are operationally significant but are not fully defined within this Determination, requiring consultation of the Act and related instruments (secs 4–5).","Potential compliance burden on pharmacies to charge at or below the \"appropriate maximum price\" (s4) and for suppliers/responsible persons to justify a \"claimed price\" (s5) — possible disputes over price classification and billing."],"plain_english_summary":"This Determination sets the official maximum (“determined”) prices and records the \"claimed\" prices for specified brands, strengths and pack sizes of pharmaceutical items supplied to approved pharmacists. It also specifies when the Commonwealth will pay a special patient contribution (for certain brands supplied on an \"authority prescription\"). It repeals the prior instrument and was brought into force with later amendments that update the schedules of brands and prices."}},"importantCases":[],"_links":{"self":"/api/acts/f2007l04363","history":"/api/acts/f2007l04363/history","analysis":"/api/acts/f2007l04363/analysis","conflicts":"/api/acts/f2007l04363/conflicts","importantCases":"/api/acts/f2007l04363/important-cases","documents":"/api/acts/f2007l04363/documents"}}